ADVERTISEMENT

Syngene International Q3 Review - Growth Outlook Remains Intact: Dolat Capital

Syngene International Q3 Review - Growth Outlook Remains Intact: Dolat Capital

Clinical development services facility of Syngene International.  (Image: Company website)
Clinical development services facility of Syngene International.  (Image: Company website)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More